DVT prophylaxis in orthopaedic oncology patients - A safety study
Latest Information Update: 25 Jan 2021
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Deep vein thrombosis
- Focus Adverse reactions
- 22 Jun 2020 Status changed from active, no longer recruiting to completed.
- 31 Oct 2019 Planned End Date changed from 31 Jul 2019 to 31 Oct 2021.
- 31 Oct 2019 Planned primary completion date changed from 31 Jul 2019 to 31 Oct 2021.